The sequencing of the human genome promises to provide numerous new proteins as drug targets and therapeutic agents. We are investigating several obstacles to the efficient commercialization of these delicate molecules. In addition, we are exploring protein misfolding relating to human disease.
B.S. in Chemical Engineering, California Institute of Technology in 1984,Ph.D. in Chemical Engineering, University of California Berkley in 1989,
Molecular Scale Analysis of Protein Adsorption, Purification, and Biointerfaces
Aggregation of Protein Biopharmaceuticals